Monday, May 11, 2026
Today's Print

Tag: Gilead Sciences

HIV-prevention drug to be available for $40 a year from 2027

Geneva, Switzerland—Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 countries from 2027, Unitaid and...

South Korea follows US, Japan to use remdesivir

South Korea on Wednesday issued an emergency authorisation for the anti-viral drug remdesivir to be used to treat coronavirus patients, paving the way for...

Remdesivir: The COVID-19 drug helping patients recover faster

Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven...
- Advertisement -spot_img
- Advertisement -spot_img